Another week has flown by, and yet more interesting cancer research was in the news, both from our own scientists and from research groups around the world. We’ve summarised the big stories of the week below. Click on the links … Continue reading →
For regular readers, alcohol and breast cancer may seem like old news, and you might wonder why it’s hit the headlines again. But solid new data from a team of international researchers gives a new, more accurate estimate of how … Continue reading →
Developing new drugs is hard. Only a small fraction of chemicals tested in the lab and early patient trials ultimately make it into routine use. Most fall at one of many hurdles on the way – hurdles as diverse as … Continue reading →
Alcohol has been a well-loved but problematic part of British life for centuries, as immortalised in 18th century artist Hogarth’s depictions of “Gin Lane” and “Beer Street”. In its latest steps to try to tackle England’s long-standing and complex relationship … Continue reading →
Last year, the surprising discovery of chromothripsis– literally translated as “chromosome shattering” – revealed an entirely novel way for the DNA in cancer cells to get messed up, and opened the door to new ideas about how tumours develop and … Continue reading →
This week’s news digest includes our take on aspirin and cancer; a report about the huge profits the tobacco industry makes through selling it’s deadly product; encouraging early research to tackle pancreatic cancer; and a whole lot more. Scroll through … Continue reading →
Yesterday’s announcement that the Scottish government will trial a new lung cancer test has been widely covered in this morning’s media – both on TV and in the papers. In case you missed the story, the NHS in Scotland is … Continue reading →
In this month’s podcast a landmark cancer study sheds light on tumour genes, and experts suggest that more breast cancer patients should have genetic tests. New figures reveal worrying numbers of schoolchildren taking up smoking, and leading model agencies sign up … Continue reading →
“Should I be taking aspirin to reduce the risk of dying from cancer?” This is likely to be the question on many people’s minds today, which sees the publication of three reports on the effects of aspirin on cancer risk, … Continue reading →
It was a week that started in Scotland, with the ‘no’ decision on prostate drug abiraterone, and went on to cover skin cancer, No Smoking Day, oral cancer, shisha pipes, prostate screening and cancer-munching blood cells. In short, it was … Continue reading →